SR 201·KY·senate
A RESOLUTION encouraging Kentucky policymakers to study, develop, and implement economic development policies to incentivize biopharmaceutical investment and innovation in Kentucky.
Passed One ChamberFiled Mar 26, 2026
Latest Action
adopted by voice vote
Apr 1, 2026
Summary
The Senate passed a resolution encouraging state policymakers to examine, design, and adopt economic policies that would attract biopharma companies to Kentucky. It highlights the potential for high‑paying jobs and urges incentives such as tax credits, grants, and dedicated funding pools. The measure is symbolic, aiming to keep talent and research in the state.
AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.
Topics
Track this bill
Get real-time alerts when SR 201 changes status, plus AI-powered summaries and stage predictions.
Sign up free